Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lyell Immunopharma (LYEL) Prepaid Assets (2020 - 2025)

Lyell Immunopharma (LYEL) has disclosed Prepaid Assets for 6 consecutive years, with $13.7 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 51.31% to $13.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.7 million through Dec 2025, up 51.31% year-over-year, with the annual reading at $13.7 million for FY2025, 51.31% up from the prior year.
  • Prepaid Assets hit $13.7 million in Q4 2025 for Lyell Immunopharma, up from $8.6 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $13.7 million in Q4 2025 to a low of $5.4 million in Q2 2025.
  • Historically, Prepaid Assets has averaged $10.1 million across 5 years, with a median of $10.7 million in 2023.
  • Biggest five-year swings in Prepaid Assets: skyrocketed 133.2% in 2021 and later tumbled 37.69% in 2025.
  • Year by year, Prepaid Assets stood at $11.5 million in 2021, then fell by 3.04% to $11.1 million in 2022, then dropped by 24.05% to $8.5 million in 2023, then rose by 7.14% to $9.1 million in 2024, then surged by 51.31% to $13.7 million in 2025.
  • Business Quant data shows Prepaid Assets for LYEL at $13.7 million in Q4 2025, $8.6 million in Q3 2025, and $5.4 million in Q2 2025.